Table 1.
Baseline patient characteristics.
| Non NAFLD Patients (n = 42) |
NAFLD Patients (n = 55) |
p-value | NAFLD Standard of Care Group (n = 28) |
NAFLD Intervention Group (n = 27) |
p-value | |
|---|---|---|---|---|---|---|
| Sex (%) | ||||||
| Male | 76.2 (32) | 72.7 (40) | >0,05 | 71.4 (20) | 74.1 (20) | >0,05 |
| Female | 23.8 (10) | 27.3 (15) | 28.6 (8) | 25.9 (7) | ||
| Age (years) | 55.1 ± 13.7 | 54.2 ± 10.9 | >0,05 | 55.9 ± 11.7 | 52.6 ± 9.9 | >0,05 |
| Weight (kg) | 71.5 ± 12.0 | 78.3 ± 10.4 | 0.04 | 77.8 ± 9.9 | 78.9 ± 11.1 | >0,05 |
| BMI (kg/m2) | 24.7 ± 3.4 | 27.9 ± 4.4 | 0.001 | 28.1 ± 4.0 | 27.7 ± 4.9 | >0,05 |
| BMI category (%) | ||||||
| Normal (18.5–24.9 kg/m2) | 47.6 (20) | 29.1 (16) | 0.01 | 25.0 (7) | 33.3 (9) | >0,05 |
| Overweight (25–29.9 kg/m2) | 47.6 (20) | 43.6 (24) | 46.4 (13) | 40.7 (11) | ||
| Obesity (≥30 kg/m2) | 4.8 (2) | 27.3 (15) | 28.6 (8) | 25.9 (7) | ||
| Waist circumference (cm) | 91.3 ± 9.9 | 98.3 ± 10.2 | 0.005 | 98.1 ± 10.6 | 98.5 ± 9.9 | >0,05 |
| AST | 23.3 ± 7.1 | 24.1 ± 9.1 | >0,05 | 23.5 ± 7.7 | 24.7 ± 10.5 | >0,05 |
| % above threshold | 16.7 (7) | 10.9 (6) | >0,05 | 7.1 (2) | 14.8 (4) | |
| ALT | 25.4 ± 9.8 | 30.9 ± 10.1 | >0,05 | 28.8 ± 16.1 | 33.0 ± 19.8 | >0,05 |
| % above threshold | 16.7 (7) | 27.3 (15) | >0,05 | 28.6 (8) | 25.9 (7) | |
| HIV diagnosis time (years) | 17.9 ± 9.2 | 18.0 ± 7.6 | >0,05 | 17.2 ± 7.1 | 18.4 ± 8.1 | >0,05 |
| T-CD4+cell ≥500 cel/mm3 | 73.8 (31) | 90.9 (50) | 0.025 | 82.1 (23) | 100 (27) | 0.021 |
| Type 2 diabetes mellitus (%) | 19.0 (8) | 15.4 (9) | >0,05 | 17.9 (5) | 14.8 (4) | >0,05 |
| High blood pressure (%) | 40.5 (17) | 43.6 (24) | >0.05 | 53.6 (15) | 33.3 (9) | >0,05 |
| Dyslipidaemia (%) | 35.7 (15) | 52.7 (29) | 0.095 | 50.0 (14) | 55.6 (15) | >0,05 |